Jeffrey Abbey Insider Profile
4 Followers
Jeffrey Abbey, former CEO, Director at Argos Therapeutics, holds 25.45K shares in Argos Therapeutics (Ticker: ARGSQ).
Jeffrey Abbey's Trading History
You May Also Like
Jeffrey Abbey insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Abbey?
The percentage of profitable transactions made by Jeffrey Abbey is 67%.
What is the average return per transaction made by Jeffrey Abbey?
The average return per transaction made by Jeffrey Abbey is 45.70%.
What stocks does Jeffrey Abbey hold?
Jeffrey Abbey holds: ARGSQ stocks.
What was Jeffrey Abbey's most profitable transaction?
Jeffrey Abbey’s most profitable transaction was an Informative Buy of ARGSQ stock on December 17, 2015. The return on the trade was 152.70%.
What is Jeffrey Abbey's role in Argos Therapeutics?
Jeffrey Abbey's role in Argos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
